A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency.
Neven, Bénédicte; Mamessier, Emilie; Bruneau, Julie; Kaltenbach, Sophie; Kotlarz, Daniel; Suarez, Felipe; Masliah-Planchon, Julien; Billot, Katy; Canioni, Danielle; Frange, Pierre; Radford-Weiss, Isabelle; Asnafi, Vahid; Murugan, Dhaarini; Bole, Christine; Nitschke, Patrick; Goulet, Olivier; Casanova, Jean-Laurent; Blanche, Stéphane; Picard, Capucine; Hermine, Olivier; Rieux-Laucat, Frederic; Brousse, Nicole; Davi, Frederic; Baud, Véronique; Klein, Christoph; Nadel, Bertrand; Ruemmele, Frank; Fischer, Alain.
; 122(23): 3713-22, 2013 Nov 28.
Artigo em Inglês | MEDLINE | ID: mdl-24089328
No immunosurveillance in human IL-10R deficiency.
The age of gene discovery in very early onset inflammatory bowel disease.
Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.
Monogenic autoinflammatory diseases: Cytokinopathies.
The structural network of Interleukin-10 and its implications in inflammation and cancer.
Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease.
Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations.
Investigation of Genetic Defects in Severe Combined Immunodeficiency Patients from Turkey by Targeted Sequencing.
Interleukin-10 in inflammatory bowel disease.